Description

• • This dual-peptide formulation of VIP and BPC-157 is supplied for research use only, and studied in models exploring cellular signaling and tissue regulation.
  • Vasoactive Intestinal Peptide (VIP) is evaluated in preclinical models for its potential involvement in immune signaling and anti-inflammatory processes.
  • BPC-157 is investigated for its role in angiogenesis, cell migration, and gastrointestinal system response under stress conditions.
  • The combination has been studied for potential synergy in vascular health, mucosal protection, and cellular response to injury.
  • Used in experimental settings involving neuroinflammation, immune modulation, and gut-brain axis research.